Biotech · Private company
Aadi Bioscience, Inc.
Track this companyFree. Adds Aadi Bioscience, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials142 recruiting or active
Pipeline programs15From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline15
- ABI-009Phase 2 · Non-muscle Invasive Bladder Cancer (NMIBC)ClinicalTrials.gov · fetched Nov 12, 2026
- GemcitabinePhase 2 · Non-muscle Invasive Bladder Cancer (NMIBC)ClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimusPhase 2 · Colorectal Cancer MetastaticClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimusPhase 2 · Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimusPhase 2 · High Grade Recurrent Glioma and Newly Diagnosed GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimusPhase 2 · Neuroendocrine TumorsClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimusPhase 2 · TumorClinicalTrials.gov · fetched Nov 12, 2026
- nab-SirolimusPhase 2 · Malignant PEComaClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimus + bevacizumabPhase 2 · High Grade Recurrent Glioma and Newly Diagnosed GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimus + lomustinePhase 2 · High Grade Recurrent Glioma and Newly Diagnosed GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimus + marizomib (MRZ)Phase 2 · High Grade Recurrent Glioma and Newly Diagnosed GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimus + temozolomidePhase 2 · High Grade Recurrent Glioma and Newly Diagnosed GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimus + temozolomide + radiotherapyPhase 2 · High Grade Recurrent Glioma and Newly Diagnosed GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimusPhase 1 · Pulmonary HypertensionClinicalTrials.gov · fetched Nov 12, 2026
- nab-sirolimusPhase 1 · Tumor, SolidClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials14
- Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)PHASE2 · ACTIVE_NOT_RECRUITING · started Dec 26, 2024ClinicalTrials.gov NCT06494150 · fetched Nov 12, 2026
- Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial CancerPHASE2 · RECRUITING · started Dec 28, 2023ClinicalTrials.gov NCT05997017 · fetched Nov 12, 2026
- Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR InhibitorsPHASE2 · COMPLETED · started Oct 20, 2023ClinicalTrials.gov NCT05997056 · fetched Nov 12, 2026
- Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)PHASE1 · TERMINATED · started Aug 7, 2023ClinicalTrials.gov NCT05840510 · fetched Nov 12, 2026
- Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver ImpairmentPHASE1 · COMPLETED · started Nov 23, 2022ClinicalTrials.gov NCT05661461 · fetched Nov 12, 2026
- Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)PHASE2 · COMPLETED · started Mar 10, 2022ClinicalTrials.gov NCT05103358 · fetched Nov 12, 2026
- Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue SarcomasPHASE1_PHASE2 · TERMINATED · started Apr 1, 2019ClinicalTrials.gov NCT03660930 · fetched Nov 12, 2026
- Nab-sirolimus in Recurrent High Grade Glioma and Newly Diagnosed GlioblastomaPHASE2 · COMPLETED · started Aug 1, 2018ClinicalTrials.gov NCT03463265 · fetched Nov 12, 2026
- ABI-009 (Nab-rapamycin) for Surgically-Refractory Epilepsy (RaSuRE)PHASE1 · COMPLETED · started Jul 31, 2018ClinicalTrials.gov NCT03646240 · fetched Nov 12, 2026
- Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal CancerPHASE1_PHASE2 · COMPLETED · started Jul 1, 2018ClinicalTrials.gov NCT03439462 · fetched Nov 12, 2026
- Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain CancersPHASE1_PHASE2 · COMPLETED · started Aug 24, 2017ClinicalTrials.gov NCT03190174 · fetched Nov 12, 2026
- Phase 1/1b Study With Nab-sirolimus for Patients With Severe Pulmonary Arterial HypertensionPHASE1 · COMPLETED · started Apr 1, 2017ClinicalTrials.gov NCT02587325 · fetched Nov 12, 2026
- A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComaPHASE2 · COMPLETED · started Oct 1, 2015ClinicalTrials.gov NCT02494570 · fetched Nov 12, 2026
- Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder CancerPHASE1_PHASE2 · COMPLETED · started Apr 9, 2014ClinicalTrials.gov NCT02009332 · fetched Nov 12, 2026